{"name":"Nuvectis Pharma, Inc.","slug":"nuvectis-pharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE52cHhmNFFZX1NYUG5qUncxbUVYN3g0RU5wTFQ4ams0VXZUcHZtLXdKaG5JWWVVMVZCY1dQZklNVm11TnNPeFBweFZ2dDdNWEdPMzhRNHIzTy0tWGFieExJ?oc=5","date":"2026-04-02","type":"pipeline","source":"ChartMill","summary":"NVCT Stock Price, Quote & Chart | NUVECTIS PHARMA INC (NASDAQ:NVCT) - ChartMill","headline":"NVCT Stock Price, Quote & Chart | NUVECTIS PHARMA INC (NASDAQ:NVCT)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQYXdneUlYRHZ1M0U2NzVVcjgwUzFncWduWUk5U2c5dW44UUdtTXF5eU9TZzFlTjNDanpZTzQxWS01VUpZUElQT3JYWmN6ZFlPQVowcVhvQ2FLbG4wOHBuRjFDSmZfdW50eW5LeFB2My1BdS1YUTZCWTY0RXdiNVNYSkNzNnJLWmxKSllwREo3dzJtLXFSQl9PcFpRLTM0eGJfVG1uOG1oM292RzJNLXViNGJJbU8xV28?oc=5","date":"2026-04-02","type":"pipeline","source":"MarketBeat","summary":"Nuvectis Pharma (NASDAQ:NVCT) Trading Down 1.7% - Here's What Happened - MarketBeat","headline":"Nuvectis Pharma (NASDAQ:NVCT) Trading Down 1.7% - Here's What Happened","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxNWFRZeGFzNTB0TFZpRV8xMExybGJsZ0hmZEIwd0xqYkNvTHFUS3hST2hDNEFvdlozRXA3UDNBZkhNY3h1b2huMzJjdXNfR2hwcWhZRUtFQndnS216R1RMMmlWSkRPZzdEOTl5WS1sWWF0LWs2YzFmXzc5VW9uUElMSWQxXzZNMDFJSnhhY2RsTWlyQkIyOG9qTm5PYllZSHF5RkxVcXo2d2E4VnpULTBacUMwUng2RU1aOHFRT1ZYcERuNncxUk9jNXhqcU1tZ09famJZdnNiYl9FY3p0aG4ybDZ2d2xIczk5SDN5NXduZnBkZWRjS2xIU2ZIbkdaaEtLWWZKTEgyd3dDYkZPZTNJRG1EMkJZdVV4bE94Mg?oc=5","date":"2026-03-31","type":"pipeline","source":"GlobeNewswire","summary":"Nuvectis Pharma Announces Upcoming Presentations for NXP900 - GlobeNewswire","headline":"Nuvectis Pharma Announces Upcoming Presentations for NXP900","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxNTXBiQUZtX2pSOXpGTWRUcDgtNFpxWmlndUJpSk0weElwcVpzY1pDcWhORGFPNGdBZXdvUEotT0p5cGpRMHl5VzJGSlpveHZEYUZMZ2hmVVctUzd0NmZUOUp0RVAycU1xZm5UZ2ItTzRFNEMxaE1kOTUwYk5HUkN6TmZjdjBBRGVUVU9oNzVLNkozWC10YkJHeHBsTTFSUUJhdTU1ZW1BZktBalBzYTFsa1lEY2JvY1ZOTWZ1ME5SMU1sYzB1RG82SG9DQndmLXhjeU1QNC1NX2hCcjBhZll3Yk9XUEVRemxQ?oc=5","date":"2026-03-31","type":"pipeline","source":"marketscreener.com","summary":"Nuvectis Pharma announces upcoming presentations for NXP900 at the 2026 American Association for Cancer Research meeting - marketscreener.com","headline":"Nuvectis Pharma announces upcoming presentations for NXP900 at the 2026 American Association for Cancer Research meeting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOTVlVdkxwYWtVeEN6VFN1WHI3NnRsaUE2Uzl0ZlVaN2NJOGZST2FjeTZFcC00Ty04NF8yeEV6TlFxNXRWRlQzcXV2MFdFNzdhSjlZWlBrNHdZV2tJYVdHOWl6NHdhV0NXUXU2M1RORnBRZ040VjNQMDN4U3NsLXFVWVZZUk9oNm1ET0VIMnNka0E?oc=5","date":"2026-03-24","type":"pipeline","source":"Yahoo Finance","summary":"Here's Why We're Not Too Worried About Nuvectis Pharma's (NASDAQ:NVCT) Cash Burn Situation - Yahoo Finance","headline":"Here's Why We're Not Too Worried About Nuvectis Pharma's (NASDAQ:NVCT) Cash Burn Situation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNRlRQMTBJSlp2X3pZNFFlOE1DUGFBQm1uaFBNclZwZzZfd2V2eUZTQUV3NWlDVmRYeUZHUVNVdTBDaHNRQWw4LXdKR00taHlucTl0VDNSd2NUbnZVWUFMNHlocWRoaTlPUW9PSm02ZGtDZTF1WXl2R3V6TjVqQUU2WXJ3dFBCM3lOTVdzOHduUWo4c183d1ctUENWQ3ZoQzVTNzlXdnhEcnFxVnVJZjYwUFRNZEk1UXBTTkxjblNSdUpWSVBPdHUyRFJWTFZFTGU3bmtiUk9xWWZPSjdfU2k4?oc=5","date":"2026-02-11","type":"pipeline","source":"GlobeNewswire","summary":"Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights - GlobeNewswire","headline":"Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-09","type":"pipeline","source":"simplywall.st","summary":"We Think Nuvectis Pharma (NASDAQ:NVCT) Can Afford To Drive Business Growth - simplywall.st","headline":"We Think Nuvectis Pharma (NASDAQ:NVCT) Can Afford To Drive Business Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxPb0NaRjJHT1VxeDFXSlNKMWlZb2gxdGxsZ0dYN1g4YzYxMVduR25IYkFFUHFBOGpFVVFUb1dzcC1za2hGbTk4X3ZBMG5WeHRNSFRkbzdUMkxSbkZtQjZZSU05elZCN3hVNkNPU3ozRDF3dDBHSmY4dlZEVS0zeWhkdGo4S3g2ZEE1cDN4ZjlfVzF4czdvYzBmOVczNXNON3Ffa3I5eTN3dk5DeEVKeWxmenRDa3Vycjg2YzB0MFVtVm91enktM2dLbWNoN3hpUmtHZHFTVkVqeEREaG96dGhmQ3VhTWVSWHJrTFBJaTkzdllsSUg2NmRWTlZQRHJ1TENQdmU3R0ZtWG54bmN5QmVpOTEteXJXZzBEdGV0TWFfOXJ0dGtWYXc?oc=5","date":"2025-12-17","type":"trial","source":"GlobeNewswire","summary":"Nuvectis Pharma Announces the Initiation of the Phase 1b - GlobeNewswire","headline":"Nuvectis Pharma Announces the Initiation of the Phase 1b","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-05","type":"earnings","source":"simplywall.st","summary":"Nuvectis Pharma, Inc.'s (NASDAQ:NVCT) market cap rose US$18m last week; individual investors who hold 44% profited and so did insiders - simplywall.st","headline":"Nuvectis Pharma, Inc.'s (NASDAQ:NVCT) market cap rose US$18m last week; individual investors who hold 44% profited and s","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPLTUyR0M2bElnQmJlQXpQbm1zUWNMLXY2VWJrWWNjbXh6VW5qenJOb3R3ZGJobHZpREJ4SmYzaWtwd2JxQzVmUkNxdS1fZVR3TlRBcHhWRkZUeHVUMnFjMDlrOW4zVHBMbGFVb25CY0FaVGhVem9EOVdDVGp0MU1RNl8tQmhRdw?oc=5","date":"2025-11-04","type":"earnings","source":"Yahoo Finance","summary":"Nuvectis Pharma, Inc. Reports Third Quarter 2025 Financial Results and Business Highlights - Yahoo Finance","headline":"Nuvectis Pharma, Inc. Reports Third Quarter 2025 Financial Results and Business Highlights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPT19XTnFQV2VWNDZManFzRVRlN3BKUTdYWUlWOVEwb0drS3ROa05jeG9mNlZmOW8yXzNMeHk5QXUtYnNwemxaaXdSVkt2SXJ4ajE4VmEyVjNmQ3A4djlQQnVVVmZvcWVpQlR1d1duVkVacy1zZ3VSWW92aDEzUlZLSU1NNVZuT1lBVTliTU9RYVZlX1Y3X2RxRHpR?oc=5","date":"2025-10-16","type":"pipeline","source":"Yahoo Finance","summary":"Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Yahoo Finance","headline":"Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 AACR-NCI-EORTC International Conference on Molec","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPZTVzOFNHeV9tdGROVVhOY3RhR1dFRThlRmpWZ25Wc3M5SEI4b2I1OTRQQTJaRWs0UktaU3FJVWJVOHYzM3Z2am9RdjNuYWkyLXRyRjUzZ2huTjNCMk9oSTdCbVF1SjdvMlJ3cC11MjVnNmxSVTFmbEJIeTZ6YTNQd1ktbjJMVDhjaXJBYkhxN3ZTVTAtcFhvNjJLQnRkMDdGTU5CV3lfTHIzZDQ?oc=5","date":"2025-08-04","type":"trial","source":"Clinical Trials Arena","summary":"Nuvectis Pharma cuts NXP800 in ovarian cancer after early failure - Clinical Trials Arena","headline":"Nuvectis Pharma cuts NXP800 in ovarian cancer after early failure","sentiment":"negative"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}